Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2.
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2.
复制标题
DOI：
10.1007/s10147-021-02076-7
复制
发表时间：
2022-03
影响因子：
3.3
通讯作者：
Osuga Y
中科院分区：
文献类型：
--
作者：
Tozawa A;Kimura F;Takai Y;Nakajima T;Ushijima K;Kobayashi H;Satoh T;Harada M;Sugimoto K;Saji S;Shimizu C;Akiyama K;Bando H;Kuwahara A;Furui T;Okada H;Kawai K;Shinohara N;Nagao K;Kitajima M;Suenobu S;Soejima T;Miyachi M;Miyoshi Y;Yoneda A;Horie A;Ishida Y;Usui N;Kanda Y;Fujii N;Endo M;Nakayama R;Hoshi M;Yonemoto T;Kiyotani C;Okita N;Baba E;Muto M;Kikuchi I;Morishige KI;Tsugawa K;Nishiyama H;Hosoi H;Tanimoto M;Kawai A;Sugiyama K;Boku N;Yonemura M;Hayashi N;Aoki D;Suzuki N;Osuga Y
日本临床肿瘤学会（JSCO）于2017年发布了《JSCO儿童、青少年和年轻成人癌症患者生育力保护临床实践指南2017》。这是日本第一个癌症生殖医学指南。在癌症生殖医学领域，从治疗开始前到治疗后很长一段时间，肿瘤学家和生殖医学医生之间的密切合作非常重要。该指南考虑了疾病的特异性，并从肿瘤学家和生殖医学专家的角度提供了符合日本医疗体系现状的意见。它旨在为两个领域的医务人员提供参考，以了解在癌症治疗开始之前是否可以进行生育力保留治疗。适当使用该指南可以更容易地确定生育力保留治疗是否可行，并最终提高儿童，青少年和年轻成年癌症患者的生存率。在本文（第2部分）中，我们按器官/系统以及儿科癌症描述了详细信息。在线版本包含补充材料，可通过10.1007/s10147-021-02076-7获得。
The Japan Society of Clinical Oncology (JSCO) published the “JSCO Clinical Practice Guidelines 2017 for Fertility Preservation in Childhood, Adolescent, and Young Adult Cancer Patients” in 2017. This was the first guideline in cancer reproductive medicine in Japan. In the field of cancer reproductive medicine, close cooperation between an oncologist and a physician for reproductive medicine is important from before treatment initiation until long after treatment. The guideline takes into consideration disease specificity and provides opinions from the perspective of oncologists and specialists in reproductive medicine that are in line with the current state of the Japanese medical system. It is intended to serve as a reference for medical staff in both fields regarding the availability of fertility preservation therapy before the start of cancer treatment. Appropriate use of this guideline makes it easier to determine whether fertility preservation therapy is feasible and, ultimately, to improve survivorship in childhood, adolescent, and young adult cancer patients. In this article (Part 2), we describe details by organ/system and also for pediatric cancer. The online version contains supplementary material available at 10.1007/s10147-021-02076-7.
登录
查看更多内容
影响因子：
3.7
作者：
Wallace, W. Hamish B.;Kelsey, Thomas W.
通讯作者：
Kelsey, Thomas W.
影响因子：
3.9
作者：
Pagani, Olivia;Ruggeri, Monica;Partridge, Ann H.
通讯作者：
Partridge, Ann H.
影响因子：
3.3
作者：
Harada M;Kimura F;Takai Y;Nakajima T;Ushijima K;Kobayashi H;Satoh T;Tozawa A;Sugimoto K;Saji S;Shimizu C;Akiyama K;Bando H;Kuwahara A;Furui T;Okada H;Kawai K;Shinohara N;Nagao K;Kitajima M;Suenobu S;Soejima T;Miyachi M;Miyoshi Y;Yoneda A;Horie A;Ishida Y;Usui N;Kanda Y;Fujii N;Endo M;Nakayama R;Hoshi M;Yonemoto T;Kiyotani C;Okita N;Baba E;Muto M;Kikuchi I;Morishige KI;Tsugawa K;Nishiyama H;Hosoi H;Tanimoto M;Kawai A;Sugiyama K;Boku N;Yonemura M;Hayashi N;Aoki D;Osuga Y;Suzuki N
通讯作者：
Suzuki N
影响因子：
45.3
作者：
Loren, Alison W.;Mangu, Pamela B.;Oktay, Kutluk
通讯作者：
Oktay, Kutluk